Change in the susceptibility of multidrug-resistant Gram-negative pathogens to third-generation cephalosporins and fluoroquinolones after the introduction of preauthorization
Oral and General Health · 27.06.2026 · 7 (2) · 62-67
DOI: 10.22141/ogh.7.2.2026.299 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral and General Health, online erschienen am 27.06.2026. Verfasst von M.V. Khaitovych und 4 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Antimicrobial resistance among Gram-negative bacteria is one of the most important challenges in modern surgery, as it significantly complicates the treatment of infections, increases mortality, length of stay, and healthcare costs. Objective: to assess changes in the antimicrobial susceptibility of multidrug-resistant Gram-negative pathogens following the introduction of preauthorization system for antibacterial therapy. Materials and methods. A retrospective analysis of local microbiological surveillance data was performed. Particular attention was paid to changes in the susceptibility of Klebsiella pneumoniae and Acinetobacter baumannii to third-generation cephalosporins and fluoroquinolones.
Results
Following the introduction of preauthorization, a positive trend was observed in the antimicrobial susceptibility of the major Gram-negative bacteria. The susceptibility of Klebsiella pneumoniae to third-generation cephalosporins increased from 28.6 % in 2023 to 50.0 % in 2025, to ciprofloxacin from 42.9 to 64.0 %, to amikacin from 42.9 to 64.0 %, and to meropenem from 42.9 to 50.0 %. After a temporary decrease in susceptibility to cephalosporins and fluoroquinolones in 2024, a substantial recovery was observed in 2025. Regarding Acinetobacter baumannii, the most pronounced changes were observed for third-generation cephalosporins and fluoroquinolones: whereas virtually no susceptible isolates were identified in 2023–2024, approximately 42 % of strains were susceptible to these agents in 2025. An increase in susceptibility to amikacin and carbapenems was also observed. These findings indicate a gradual reduction in selective pressure following restrictions on the use of ceftriaxone and levofloxacin and support the feasibility of preauthorization introduction into comprehensive antimicrobial stewardship programs.
Conclusions
Preauthorization of broad-spectrum antibiotics is associated with improved local susceptibility of multidrug-resistant Gram-negative pathogens, primarily Klebsiella pneumoniae and Acinetobacter baumannii, to third-generation cephalosporins and fluoroquinolones.
Zitieren
APA
Khaitovych, M., Vitіuk, O., Krasyuk, S., Turchak, D., & Niecwietajewa, I. (2026). Change in the susceptibility of multidrug-resistant Gram-negative pathogens to third-generation cephalosporins and fluoroquinolones after the introduction of preauthorization. Oral and General Health, 7(2), 62-67. https://doi.org/10.22141/ogh.7.2.2026.299
Vancouver
Khaitovych M, Vitіuk O, Krasyuk S, Turchak D, Niecwietajewa I. Change in the susceptibility of multidrug-resistant Gram-negative pathogens to third-generation cephalosporins and fluoroquinolones after the introduction of preauthorization. Oral and General Health. 2026;7(2):62-67. doi:10.22141/ogh.7.2.2026.299
BibTeX
@article{Khaitovych2026,
author = {Khaitovych, M.V. and Vitіuk, O.O. and Krasyuk, S.P. and Turchak, D.V. and Niecwietajewa, I.},
title = {Change in the susceptibility of multidrug-resistant Gram-negative pathogens to third-generation cephalosporins and fluoroquinolones after the introduction of preauthorization},
journal = {Oral and General Health},
year = {2026},
volume = {7},
number = {2},
pages = {62--67},
doi = {10.22141/ogh.7.2.2026.299}
}
EUVIMED